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Abstract: Proliferation-differentiation balance of epithelial cells is regulated by krüppel-like factors (KLF) 4 and 5, 
and the unbalanced expression relates to carcinoma progression. However, little is known about the expression and 
role in oral carcinomas. This study examined expression of KLF4 and KLF 5 in the carcinomas by immunohistochem-
istry (n = 67) and the involvement in proliferation and differentiation of carcinoma cells. KLF4 was detected in ke-
ratinizing carcinoma cells and KLF5 in non-keratinizing cells. KLF4 staining declined in the patient with lymph node 
metastasis (P < 0.05) and in parallel with the histological dedifferentiation (P = 0.09). Exogenous overexpression of 
./)DUUDQJHGFHOOVLQDFREEOHOLNHVWUXFWXUHZLWKGHVPRVRPHVDQG./)HORQJDWHGFHOOVOLNHÀEUREODVWVZLWKRXW
GHVPRVRPHV./)VXSSUHVVHGÀEURQHFWLQH[SUHVVLRQDQG./)GRZQUHJXODWHGDQGGHJUDGHG(FDGKHULQ7KH
proliferation was not affected by KLFs. Thus, down-regulation of KLF4 and up-regulation of KLF5 may stimulate oral 
carcinoma progression through the dedifferentiation of carcinoma cells.
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Introduction
Over 50% of patients with oral squamous cell 
carcinomas (OSCCs) experience a relapse [1]. 
Phenotypic alterations of carcinoma cells prog-
ress carcinomas to the more advanced states 
[2], and the inhibition of differentiation and sus-
tained proliferation are the most prominent 
features of the aggressive subset [3, 4]. 
Carcinoma cells loose characteristics of epithe-
lial cells and dedifferentiate into mesenchymal 
cell-like cells especially at the invasive front of 
carcinoma cells in the patients with worst prog-
nosis [5-7].
Krüppel-like factors (KLFs) are developmentally 
regulated transcription factors that bind to 
GC-rich elements in the promoter of target 
genes and consist of 17 members in human. In 
contrast to the ubiquitous expression such as 
KLF6/10/11, KLF4 and KLF5 are preferentially 
expressed in epithelial cells. KLF4 is expressed 
in post-mitotic differentiating epithelial cells 
and KLF5 in less-differentiated proliferating 
epithelial cells, indicating that they coordinately 
regulate epithelial development and homeosta-
sis in an opposite fashion [8]. Previous studies 
documented their aberrant expression contrib-
utes to progression of adenocarcinomas and 
transitional cell carcinomas, but it is obscure in 
squamous cell carcinomas [9, 10]. Although 
KLF4 and KLF5 are strongly expressed in 
embryonic stem cells, genes regulated by KLF5 
in embryonic stem cells and primary cultured 
keratinocytes are largely different [11], indicat-
ing the divergent role in different cell-types. In 
this study, we examined the expression in 
OSCCs and the role in carcinoma cell pheno-
types focusing on proliferation and differenti- 
ation.
Materials and methods
OSCC cells and tissues
OSCC cell lines (Ca9.22, Ho1-u-1, HOC313, 
HSC2, HSC3, KOSC2, OSC10, SCCKN and TSU) 
and a normal keratinocyte cell line, HaCaT [12], 
were maintained in 10% fetal bovine serum-
containing medium. OSCC tissues excised at 
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Kanazawa University Hospital were used (n = 
67). Mean age of the patients was 63.5 yrs (37-
93 yrs), and the clinicopathological data were 
listed in Table 1. Histologically normal epitheli-
um far distant from carcinomas was used as 
the normal control (n = 3). All tissues were 
obtained with the written consent of the patient 
and with approval by institutional review boards 
of Kanazawa University and Nippon Dental 
University.
Immunostaining
Unstained tissue sections microwaved in 0.01 
M sodium citrate buffer, pH 6.0, were incubat-
ed with primary antibodies against KLF4 (R&D 
Biosystems, Minneapolis, USA) and KLF5 
(Sigma-Aldrich, St. Louis, USA). The nuclear 
immunostaining was evaluated as previously 
described [13]: percentage of staining was 
scored by on a scale of 0-4; 0, totally negative; 
1, <   60%; and 
3RVLWLYHVWDLQLQJZDVFODVVLÀHGDV
weak; 2, moderate; and 3, strong at the area of 
Immunoblot
After transfection of HA-tagged KLF4 and KLF5 
cDNA or the siRNA (50 nM; KLF4, #s17793; 
KLF5, #s2116; negative control, Silencer 
Negative Control #1; Ambion, Austin, USA) for 
48 h, cells lysed in a buffer containing protease 
inhibitor cocktail (Roche Diagnostics GmbH, 
Mannheim, Germany) were applied for the 
immunoblot using antibodies to KLF4, 
E-cadherin (R&D Biosystems), KLF5, cyclin D1, 
p21Cip1/Waf1 (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA), HA (Cell Signaling Technology, 
'DQYHUV 86$ ÀEURQHFWLQ LQYROXFULQ DQG
ơDFWLQ6LJPD$OGULFK
Electron microscopy
Cells transfected with KLF cDNA or vector alone 
ZHUHFXOWXUHGIRUKDQGÀ[HGLQJOXWDU-
aldehyde and 1% osmium tetroxide, and 
embedded in Epon. Ultra-thin sections stained 
with uranyl acetate and lead citrate were 
observed using the transmission electron 
Table 1. KLF immunostaining score and clinicopathological param-
eters (n = 67)
Category Subcategory (n)
KLF4 KLF5
Mean ± SD P† Mean ± SD P†
Age < 65 yrs (38) 4.55 ± 3.89 0.07 3.84 ± 3.18 0.87
\UV 2.79 ± 2.46 3.10 ± 2.88
Gender Female (27) 4.75 ± 4.10 < 0.05 3.40 ± 2.46 0.44
Male (40) 3.13 ± 2.69 3.89 ± 3.53
T stage* T1 (13) 6.46 ± 3.84 0.13 4.56 ± 3.43 0.83
T2 (33) 2.97 ± 3.30 3.77 ± 3.34
T3 (7) 2.29 ± 1.98 1.50 ± 1.52
T4 (14) 4.07 ± 2.59 4.00 ± 2.79
N stage* N0 (39) 4.13 ± 4.69 < 0.05 3.15 ± 3.15 0.81
N1 (16) 3.56 ± 3.37 4.86 ± 2.85
N2 (11) 3.18 ± 2.44 2.71 ± 2.87
N3 (1) 1.00 8.00
Clinical stage* Stage 1 (13) 6.23 ± 3.77 0.12 4.56 ± 3.43 0.74
Stage 2 (23) 2.71 ± 3.10 2.93 ± 3.24
Stage 3 (12) 4.00 ± 3.67 4.27 ± 3.07
Stage 4 (19) 3.37 ± 2.69 3.46 ± 2.86
Differentiation Well (29) 4.93 ± 3.35 0.09 3.95 ± 3.33 0.66
Moderate (23) 3.40 ± 3.72 4.13 ± 3.40
Poor (15) 1.67 ± 1.67 3.25 ± 2.86
*Patients were categorized by tumor size (T stage) and clinical stage according 
to the UICC WHO grading system and by the stage of lymph node metastasis (N 
stage). †Pearson’s chi-square test.
strongest staining due to the 
variable staining intensity. The 
staining score was calculated 
by multiplying the percentage 
and intensity scores to give a 
value of between 0-12.
Real-time PCR
Total RNA extracted from cell 
lines was reverse-transcribed 
into cDNA and subjected to 
real-time PCR using StepOne 
Real-time PCR system and 
TaqMan probes for KLF4 
(Hs00358836_m1) or KLF5 
(Hs00156145_m1; Applied Bi- 
osystems, Foster City, USA). 
Expression levels were nor-
malized against ACTB (Taq- 
Man Endogenous Control Hu- 
man ACTB, Applied Biosys- 
tems). The expression levels 
were calculated by the stan-
dard curve method (2¨¨&W), 
and the relative fold of expres-
sion compared with that in 
HaCaT cells was determined.
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microscope (H-7500, 80 kV; Hitachi High-Tech, 
Tokyo, Japan).
Statistical analysis
Correlation of KLF staining score and clinico-
pathological parameters of carcinomas was 
analyzed by Pearson’s chi-square.
Results
Expression of KLFs
In normal oral epithelium, KLF4 was localized in 
the nucleus of suprabasal cells and KLF5 pref-
erentially in the basal cells (Figure 1). KLF4 
staining intensity was increased in the epitheli-
Figure 1. Immunohistochemical staining of KLF4 and KLF5 in oral epithelium and carcinomas. Expression of KLF4 
(A, C) and KLF5 (B, D, E) in normal oral epithelium adjacent to carcinoma cells (A, B) and in oral carcinoma tissues 
with (C, D) or without keratin pearls (E) was examined by immunostaining. Non-immune IgG instead of primary anti-
body was used as a negative control (F). Bar = 40 µm.
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um near carcinoma cells. Although the intensity 
and percentage of the staining was variable, 
91.2% and 87.5% of the cases were positively 
stained for KLF4 and KLF5, respectively. KLF4 
was primarily detected in carcinoma cells near 
the center of the carcinoma cell nests that form 
keratin pearls, and rapidly declined at the 
periphery of the nests. KLF5 was detected in 
the carcinoma cells at the periphery and 
decreased near the center. In non-keratinized 
carcinoma cell nests, KLF5 localized in carci-
noma cells throughout the nests, and KLF4 
was minimally stained (data not shown). The 
cytoplasmic staining was negligible.
Implications in carcinoma pathology
KLF staining scores with respect to the patho-
logical parameters were summarized in Table 
1./)VWDLQLQJZDVVLJQLÀFDQWO\GHFUHDVHGLQ
the tumors of advanced N-stage, suggesting an 
association with the patient prognosis. The 
patient survival in the positive group (staining 
scores 6-12, n = 20) and the negative group 
(staining scores 0 and 1, n = 26) excluding 
patients who died of other diseases (n = 7) was 
analyzed. Although the negative group lowered 
the long-term survival (P < 0.05, log-rank test), 
PXOWLYDULDWHKD]DUGDQDO\VLVVKRZHGQRVLJQLÀ-
cant difference (P = 0.40; risk ratio, -0.366; 
FRQÀGHQFHLQWHUYDOVXJ-
gesting an association of KLF4 staining with 
other parameters. The staining score tended to 
decline with the differentiation, and both the 
percentage and intensity of the staining 
decreased with dedifferentiation (percentage, 
P = 0.07; intensity, P < 0.05). The differentia-
tion state (well- vs. moderately-/poorly-differen-
tiated carcinomas) was an independent prog-
nostic determinant (P < 0.005; risk ratio, 0.652; 
 FRQÀGHQFH LQWHUYDO -1.117). The 
UROH RI WKH VLJQLÀFDQW GHFUHDVH LQPDOHVZDV
unknown since the gender equally distributed 
in each parameter (data not shown). KLF5 
staining did not associate with any parameters 
(Table 1).
Involvement in carcinoma differentiation
Differentiation of epithelial cells is intertwined 
with the cell shape. Differentiated squamous 
HSLWKHOLDOFHOOVÁDWWHQFHOOERGLHVDQGIRUPGHV-
mosome-mediated cobble-like structures, and 
WKH GHGLIIHUHQWLDWHG FHOOV HORQJDWH OLNH ÀEUR-
blasts without desmosome. Therefore we 
examined the cell shape after the transfection. 
./)ÁDWWHQHGDOPRVWDOOFDUFLQRPDFHOOVDWD
single cell level and arranged in a cobble-like 
structure at the high-density area, and KLF5 
elongated cell bodies with a front-rear polarity 
even in the high-density area (Figure 2). In elec-
tron micrograms KLF4-trasfected cells dis-
Figure 2. Morphological alterations of KLF-transfected cells. Morphological changes of carcinoma cells transfected 
YHFWRUDORQHPRFN./)RU./)F'1$&HOOVZHUHYLVXDOL]HGE\'LII4XLNVWDLQLQJ./)ÁDWWHQHGFHOOVDWDVLQJOH
cell level (arrows) and arranged in a cobble-like structure at the high-density area, and KLF5 elongated cells with a 
front-rear polarity (arrow heads). Bar = 20 µm.
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played well-developed desmosomes in con-
trast to no apparent cell-cell adhesion structure 
in KLF5-transfected cells (Figure 3).
As a preliminary examination at the protein 
level, the endogenous KLF expression was 
TXDQWLÀHG DW WKH P51$ OHYHO Figure 4A). 
Compared to normal keratinocytes HaCaT cells, 
KLF4 expression was comparable in SCCKN 
cells and Ca9.22 cells, but very small or negli-
gible in other cell lines. KLF5 was expressed 
2.29-fold higher in HSC2 cells and lower in 
other cell lines. We then transfected the cDNA 
into cells expressing KLFs at various levels 
(HSC3, Ho1-u-1, TSU, and OSC19 cells). After 
48 h transfection, E-cadherin was down-regu-
lated and/or reduced in size to 100 kDa in 
KLF5-transfected cells (Figure 4B), and KLF5 
siRNA did not change the expression of intact 
E-cadherin (Figure 4C). Involucrin was not 
affected by KLF5 cDNA, but increased by the 
VL51$DQGÀEURQHFWLQZDVQRWDIIHFWHG./)
F'1$ DSSDUHQWO\ UHGXFHG ÀEURQHFWLQ H[SUHV-
sion but did not affect expression of the differ-
HQWLDWLRQPDUNHUV./)VL51$LQFUHDVHGÀEUR-
nectin slightly.
KLFs and proliferation
Cyclin D1 was down-regulated by KLF4 in OSC19 
cells but not in other cell lines (Figure 4B). 
Expression of a proliferation negative regulator, 
p21Cip1/Waf1, was not affected by KLFs in any of 
the carcinoma cell lines examined. To analyze 
the involvement of KLFs in proliferation more 
directly, a proliferation assay was performed. 
Excluding OSC19 cells, carcinoma cells were 
not affected by KLF4 and KLF5 (Figure 5).
Discussion
Carcinomas frequently unbalance its prolifera-
tion and differentiation [8], and aggressive 
OSCCs inactivate expression of mucosa-asso-
ciated lymphoid tissue 1 that differentially reg-
ulates KLF4 and KLF5 [7, 14], suggesting an 
Figure 3. Ultrastructure of KLF-transfected cells. OSC19 cells transfected with KLF4 cDNA (D, E), KLF5 cDNA (F, 
G) or vector alone (A-C) were observed by transmission electron microscope. KLF4-trasfected cells developed des-
mosomes (open arrowheads), and KLF5-transfected cells had no apparent cell-cell adhesion structures (closed 
arrowheads). Cells transfected vector contacted with and without desmosomes. Bars = 10 µm (A, D, F) and 2 µm 
(B, C, E, G).
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impact of the KLFs on OSCC progression. It 
prompts us to examine the expression in OSCCs 
and its involvement in the proliferation and 
differentiation.
KLF4 and KLF5 differentially localized in nor-
mal epithelium covering the oral cavity, KLF4 
was found in the suprabasal cells and KLF5 in 
WKHEDVDOFHOOV,WFRQÀUPHGWKHORFDOL]DWLRQLQ
the skin [8]. The basal cells maintains a less-
differentiated state and supply newly divided 
cells into the suprabasal cell layer undergoing a 
terminal differentiation program, and the termi-
nally differentiating cells cannot re-enter the 
proliferation state [15]. Carcinoma cells basi-
cally retain the characteristics of epithelial 
cells, and keratinization is a hallmark of this dif-
ferentiation. Irregular masses composed of car-
cinoma cell nests invade into the underlying 
tissues, and keratinization takes place in the 
form of keratin pearls that are typically 
observed at the center of the nests. Thus, car-
cinoma cells near the center exhibit a more dif-
ferentiated phenotype than the cells at the 
periphery [16].
KLF4 was predominantly stained in the keratin-
izing carcinoma cells in agreement with a previ-
ous study [10]. As the staining score was 
decreased with histological dedifferentiation of 
Figure 4. Phenotypic alterations of carcinoma cells by KLFs. A: Quantitative analysis of KLF4 and KLF5 mRNA in 
oral carcinoma cell lines and normal keratinocytes (HaCaT). The relative fold of expression against HaCaT cells 
was depicted (n = 4). Bars = mean ± S.D. B: Expression of protein involved in the differentiation (E-cadherin, Invo-
lucrin), dedifferentiation (Fibronectin) and proliferation (Cyclin D1, p21
Cip1/Waf1). KLF4 (*) and KLF5 (**) expression 
ZHUHSUREHGE\DQWL+$DQWLERG\&([SUHVVLRQRI(FDGKHULQLQYROXFULQDQGÀEURQHFWLQXSRQWUDQVIHFWLRQRIVL51$
against KLF4 (siKLF4) and KLF5 (siKLF5). Endogenous KLF4 and KLF5 expression was probed with anti-KLF4 and 
-KLF5 antibodies. b-actin was used as an internal control.
KLF4/5 in oral carcinomas
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26&&V./)WUDQVIHFWHGFDUFLQRPDFHOOVÁDW-
tened and aligned in a cobble-like structure 
with well-developed desmosomes. These mor-
phological changes support an association of 
KLF4 with the differentiation. However, at the 
protein level, KLF4 did not affect the expres-
sion of differentiation markers in contrast to 
previous studies [17, 18]. Instead, it repressed 
ÀEURQHFWLQ H[SUHVVLRQ WKDW DUH UHJXODWHG E\
KLF17 binding on the gene promoter [19] and 
increased in an aggressive subset of carcino-
mas [20, 21]. These data indicate that KLF4 
suppresses dedifferentiation of the carcinoma 
cells rather than the initiation of differenti- 
ation.
In contrast, KLF5 elongated the cells with a 
front-rear polarity and impaired desmosome 
formation which are a signature of the dediffer-
entiation [22]. Although KLF5 did not affect 
ÀEURQHFWLQH[SUHVVLRQLWGHFUHDVHG(FDGKHULQ
expression and processed it into a smaller spe-
cies if not all carcinoma cells. The processing 
into a 100 kDa species is worth noting. 
E-cadherin establishes epithelial cell-cell adhe-
sion through the homophilic binding of extracel-
lular domain, and catenins bound to the cyto-
plasmic domain stabilizes E-cadherin at cell 
surface [23]. Expression of E-cadherin and 
catenins closely correlates with each other and 
rapidly declines in less-differentiated and dif-
fusely invasive OSCCs [24, 25]. Processing into 
the 100 kDa species is consistent with that by 
calpain, and calpain cleavage of the catenin-
binding site destabilizes E-cadherin-mediated 
cell-cell adhesion [26]. In addition, KLF5 siRNA 
increased involculin expression. Although fur-
WKHU LQYHVWLJDWLRQV DUH UHTXLUHG WR GHÀQH DQ
exact role of KLF5 in oral carcinoma cells, it 
appears likely that KLF5 negatively regulates 
the differentiation that eventually dedifferenti-
ates the cells.
Previous studies documented that KLF4 and 
KLF5 decelerate and accelerate proliferation of 
carcinoma cells, respectively [27, 28], and that 
they regulate expression of cyclin D1 and 
p21Cip1/Waf1 contrary [29-31]. However the cur-
rent study showed that KLFs did not change the 
proliferation and the cell cycle regulator expres-
sion except in OSC19 cells. Additional factors 
may be required to regulate the proliferation as 
H[HPSOLÀHG E\ WKH IDFW WKDW ./) RSSRVLWHO\
regulates p15INK4b expression in the presence 
RUDEVHQFHRI7*)ơ>@
KLF4 stimulates its own transcription through 
the binding to the promoter, and KLF5 repress-
es KLF4 expression by competing with the bind-
ing [33], indicating KLF5 as an up-stream 
repressor of KLF4. The present study demon-
strated that KLF4 and KLF5 suppress dediffer-
entiation and differentiation of oral carcinoma 
cells, respectively. Sequential loss of KLF4 and 
gain of KLF5 may strongly induce phenotypic 
alterations of the cells with aggressive behav-
iors such as the epithelial-mesenchymal transi-
tion [3, 4]. Since the initiation of differentiation 
and the inhibition of dedifferentiation are 
expected as a novel strategy for cancer therapy 
[2, 34], future investigations on the regulation 
of KLF4 and KLF5 expression are necessary to 
unveil a mechanism of OSCC progression.
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